Dr. Ekaterina Cleary is a Data Scientist at Consilium Scientific. She holds a PhD in Biomedical Engineering and Biotechnology from the University of Massachusetts, Lowell and a Master’s Degree in Bioinformatics from Boston University. With prior roles in academia and consulting, she now focuses on clinical trial quality, evidence generation, and the intersection of health policy and reimbursement.
Dr. Ekaterina Cleary holds a PhD in Biomedical Engineering and Biotechnology from the University of Massachusetts, Lowell and a Master’s Degree in Bioinformatics from Boston University. Her PhD thesis examined the genetic and environmental determinants of Alzheimer’s disease progression. Ekaterina completed her postdoctoral studies at the Center for Integration of Science and Industry at Bentley University, where she is best known for quantifying the substantial contribution of federal grant funding (i.e. National Institutes of Health) towards pharmaceutical drug discovery. With prior experience in academia and consulting, her current work sits at the intersection of health policy, evidence evaluation, and medical reimbursement. At Consilium Scientific, she leads the development of Evimeter, a quantitative framework that evaluates the strength of clinical evidence supporting breakthrough medical devices and diagnostics.
